Registro:

Referencias:

• Schiene, C., Fischer, G., Enzymes that catalyse the restructuring of proteins (2000) Curr Opin Struct Biol, 10, pp. 40-45
• Kang, C.B., Hong, Y., Dhe-Paganon, S., FKBP family proteins: Immunophilins with versatile biological functions (2008) Neurosignals, 16, pp. 318-325
• Li, H., Rao, A., Hogan, P.G., Interaction of calcineurin with substrates and targeting proteins (2011) Trends Cell Biol, 21, pp. 91-103
• Shimobayashi, M., Hall, M.N., Making new contacts: The mTOR network in metabolism and signalling crosstalk (2014) Nat Rev Mol Cell Biol, 15, pp. 155-162
• Pratt, W.B., Toft, D.O., Steroid receptor interactions with heat shock protein and immunophilin chaperones (1997) Endocr Rev, 18, pp. 306-360
• Breiman, A., Plant Hsp90 and its co-chaperones (2014) Curr Protein Pept Sci, 15, pp. 232-244
• Kost, S.L., Smith, D.F., Sullivan, W.P., Binding of heat shock proteins to the avian progesterone receptor (1989) Mol Cell Biol, 9, pp. 3829-3838
• Smith, D.F., Schowalter, D.B., Kost, S.L., Reconstitution of progesterone receptor with heat shock proteins (1990) Mol Endocrinol, 4, pp. 1704-1711
• Baulieu, E.E., Binart, N., Cadepond, F., Are receptor-associated nuclear proteins associated with the earliest effects of steroid hormones? (1990) Symp Soc Exp Biol, 44, pp. 3-20
• Pratt, W.B., Jolly, D.J., Pratt, D.V., A region in the steroid binding domain determines formation of the non-DNA-binding, 9 S glucocorticoid receptor complex (1988) J Biol Chem, 263, pp. 267-273
• Renoir, J.M., Radanyi, C., Faber, L.E., The non-DNA-binding heterooligomeric form of mammalian steroid hormone receptors contains a hsp90-bound 59-kilodalton protein (1990) J Biol Chem, 265, pp. 10740-10745
• Galigniana, M.D., Echeverria, P.C., Erlejman, A.G., Role of molecular chaperones and TPR-domain proteins in the cytoplasmic transport of steroid receptors and their passage through the nuclear pore (2010) Nucleus, 1, pp. 299-308
• Mazaira, G.I., Lagadari, M., Erlejman, A.G., The emerging role of TPR-domain immunophilins in the mechanism of action of steroid receptors (2014) Nucl Receptor Res, 1, p. 17
• Galigniana, M.D., Erlejman, A.G., Monte, M., The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events (2010) Mol Cell Biol, 30, pp. 1285-1298
• Wochnik, G.M., Ruegg, J., Abel, G.A., FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells (2005) J Biol Chem, 280, pp. 4609-4616
• Pekki, A., Ylikomi, T., Syvala, H., Progesterone receptor does not form oligomeric (8S), non-DNA-binding complex in intact cell nuclei (1995) J Cell Biochem, 58, pp. 95-104
• Tuohimaa, P., Pekki, A., Blauer, M., Nuclear progesterone receptor is mainly heat shock protein 90-free in vivo (1993) Proc Natl Acad Sci USA, 90, pp. 5848-5852
• Renoir, J.M., Radanyi, C., Jung-Testas, I., The nonactivated progesterone receptor is a nuclear heterooligomer (1990) J Biol Chem, 265, pp. 14402-14406
• Segnitz, B., Gehring, U., Subunit structure of the nonactivated human estrogen receptor (1995) Proc Natl Acad Sci USA, 92, pp. 2179-2183
• Pratt, W.B., Galigniana, M.D., Harrell, J.M., Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement (2004) Cell Signal, 16, pp. 857-872
• Elbi, C., Walker, D.A., Romero, G., Molecular chaperones function as steroid receptor nuclear mobility factors (2004) Proc Natl Acad Sci USA, 101, pp. 2876-2881
• Milgrom, E., (1981) Activation of Steroid-receptor Complexesed, , New York: Academic Press
• Dahmer, M.K., Housley, P.R., Pratt, W.B., Effects of molybdate and endogenous inhibitors on steroid-receptor inactivation, transformation, and translocation (1984) Annu Rev Physiol, 46, pp. 67-81
• Gasc, J.M., Renoir, J.M., Faber, L.E., Nuclear localization of two steroid receptor-associated proteins, hsp90 and p59 (1990) Exp Cell Res, 186, pp. 362-367
• Echeverria, P.C., Mazaira, G., Erlejman, A., Nuclear import of the glucocorticoid receptor-hsp90 complex through the nuclear pore complex is mediated by its interaction with Nup62 and importin beta (2009) Mol Cell Biol, 29, pp. 4788-4797
• Grossmann, C., Ruhs, S., Langenbruch, L., Nuclear shuttling precedes dimerization in mineralocorticoid receptor signaling (2012) Chem Biol, 19, pp. 742-751
• Presman, D.M., Ogara, M.F., Stortz, M., Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor (2014) PLoS Biol, 12, p. e1001813
• Barent, R.L., Nair, S.C., Carr, D.C., Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes (1998) Mol Endocrinol, 12, pp. 342-354
• Ratajczak, T., Carrello, A., Mark, P.J., The cyclophilin component of the unactivated estrogen receptor contains a tetratricopeptide repeat domain and shares identity with p59 (FKBP59) (1993) J Biol Chem, 268, pp. 13187-13192
• Banerjee, A., Periyasamy, S., Wolf, I.M., Control of glucocorticoid and progesterone receptor subcellular localization by the ligand-binding domain is mediated by distinct interactions with tetratricopeptide repeat proteins (2008) Biochemistry, 47, pp. 10471-10480
• Hinds, T.D., Jr., Sanchez, E.R., Protein phosphatase 5 (2008) Int J Biochem Cell Biol, 40, pp. 2358-2362
• Robson, T.A., Lohrer, H., Bailie, J.R., Gene regulation by low-dose ionizing radiation in a normal human lung epithelial cell line (1997) Biochem Soc Trans, 25, pp. 335-342
• Robson, T., Joiner, M.C., Wilson, G.D., A novel human stress response-related gene with a potential role in induced radioresistance (1999) Radiat Res, 152, pp. 451-461
• McCalla, D.R., Allan, R.K., Effect of actinomycin D on euglena chloroplast formation (1964) Nature, 201, pp. 504-505
• McKeen, H.D., McAlpine, K., Valentine, A., A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling (2008) Endocrinology, 149, pp. 5724-5734
• Taipale, M., Krykbaeva, I., Koeva, M., Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition (2012) Cell, 150, pp. 987-1001
• Galigniana, M.D., Harrell, J.M., O'Hagen, H.M., Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus (2004) J Biol Chem, 279, pp. 22483-22489
• Leo, C., Chen, J.D., The SRC family of nuclear receptor coactivators (2000) Gene, 245, pp. 1-11
• Werbajh, S., Nojek, I., Lanz, R., RAC-3 is a NF-kappa B coactivator (2000) FEBS Lett, 485, pp. 195-199
• Mussi, P., Yu, C., O'Malley, B.W., Stimulation of steroid receptor coactivator-3 (SRC-3) gene overexpression by a positive regulatory loop of E2F1 and SRC-3 (2006) Mol Endocrinol, 20, pp. 3105-3119
• Yan, J., Yu, C.T., Ozen, M., Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway (2006) Cancer Res, 66, pp. 11039-11046
• Arimura, A., Vn Peer, M., Schroder, A.J., The transcriptional co-activator p/CIP (NCoA-3) is up-regulated by STAT6 and serves as a positive regulator of transcriptional activation by STAT6 (2004) J Biol Chem, 279, pp. 31105-31112
• Colo, G.P., Rubio, M.F., Nojek, I.M., The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action (2008) Oncogene, 27, pp. 2430-2444
• Erlejman, A.G., De Leo, S.A., Mazaira, G.I., Transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: A role for peptidyl-prolyl isomerase activity (2014) J Biol Chem, 289, pp. 26263-26276
• Regan, P.L., Jacobs, J., Wang, G., Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma (2011) Int J Oncol, 38, pp. 105-112
• Whitesell, L., Lin, N.U., HSP90 as a platform for the assembly of more effective cancer chemotherapy (2012) Biochim Biophys Acta, 1823, pp. 756-766
• Trepel, J., Mollapour, M., Giaccone, G., Targeting the dynamic HSP90 complex in cancer (2010) Nat Rev Cancer, 10, pp. 537-549
• Denny, W.B., Prapapanich, V., Smith, D.F., Structure-function analysis of squirrel monkey FK506-binding protein 51, a potent inhibitor of glucocorticoid receptor activity (2005) Endocrinology, 146, pp. 3194-3201
• Scammell, J.G., Denny, W.B., Valentine, D.L., Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three new world primates (2001) Gen Comp Endocrinol, 124, pp. 152-165
• Reynolds, P.D., Roveda, K.P., Tucker, J.A., Glucocorticoid-resistant B-lymphoblast cell line derived from the bolivian squirrel monkey (saimiri boliviensis boliviensis) (1998) Lab Anim Sci, 48, pp. 364-370
• Hubler, T.R., Scammell, J.G., Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids (2004) Cell Stress Chaperones, 9, pp. 243-252
• Pariante, C.M., Miller, A.H., Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment (2001) Biol Psychiatry, 49, pp. 391-404
• Binder, E.B., The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders (2009) Psychoneuroendocrinology, 34, pp. S186-S195
• Galigniana, N.M., Ballmer, L.T., Toneatto, J., Regulation of the glucocorticoid response to stress-related disorders by the Hsp90-binding immunophilin FKBP51 (2012) J Neurochem, 122, pp. 4-18
• Gallo, L.I., Lagadari, M., Piwien-Pilipuk, G., The 90-kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is a mitochondrial protein that translocates to the nucleus to protect cells against oxidative stress (2011) J Biol Chem, 286, pp. 30152-30160
• Storer, C.L., Dickey, C.A., Galigniana, M.D., FKBP51 and FKBP52 in signaling and disease (2011) Trends Endocrinol Metab, 22, pp. 481-490
• Kassi, E., Moutsatsou, P., Glucocorticoid receptor signaling and prostate cancer (2011) Cancer Lett, 302, pp. 1-10
• Periyasamy, S., Hinds, T., Jr., Shemshedini, L., FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin a (2010) Oncogene, 29, pp. 1691-1701
• Yong, W., Yang, Z., Periyasamy, S., Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology (2007) J Biol Chem, 282, pp. 5026-5036
• Knudsen, K.E., Penning, T.M., Partners in crime: Deregulation of AR activity and androgen synthesis in prostate cancer (2010) Trends Endocrinol Metab, 21, pp. 315-324
• Estebanez-Perpina, E., Moore, J.M., Mar, E., The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor (2005) J Biol Chem, 280, pp. 8060-8068
• Sharifi, N., Minireview: Androgen metabolism in castration-resistant prostate cancer (2013) Mol Endocrinol, 27, pp. 708-714
• Bonkhoff, H., Berges, R., From pathogenesis to prevention of castration resistant prostate cancer (2010) Prostate, 70, pp. 100-112
• Linja, M.J., Savinainen, K.J., Saramaki, O.R., Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer (2001) Cancer Res, 61, pp. 3550-3555
• Egan, A., Dong, Y., Zhang, H., Castration-resistant prostate cancer: Adaptive responses in the androgen axis (2014) Cancer Treat Rev, 40, pp. 426-433
• Kaikkonen, S., Paakinaho, V., Sutinen, P., Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells (2013) Mol Endocrinol, 27, pp. 212-223
• Jiang, W., Cazacu, S., Xiang, C., FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway (2008) Neoplasia, 10, pp. 235-243
• Romano, S., D'Angelillo, A., Staibano, S., FK506-binding protein 51 is a possible novel tumoral marker (2010) Cell Death Dis, 1, p. e55
• Giraudier, S., Chagraoui, H., Komura, E., Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors (2002) Blood, 100, pp. 2932-2940
• Avellino, R., Romano, S., Parasole, R., Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells (2005) Blood, 106, pp. 1400-1406
• Stechschulte, L.A., Sanchez, E.R., FKBP51-a selective modulator of glucocorticoid and androgen sensitivity (2011) Curr Opin Pharmacol, 11, pp. 332-337
• Romano, S., Staibano, S., Greco, A., FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential (2013) Cell Death Dis, 4, p. e578
• Hou, J., Wang, L., FKBP5 as a selection biomarker for gemcitabine and akt inhibitors in treatment of pancreatic cancer (2012) PLoS One, 7, p. e36252
• Solassol, J., Mange, A., Maudelonde, T., FKBP family proteins as promising new biomarkers for cancer (2011) Curr Opin Pharmacol, 11, pp. 320-325
• Pei, H., Li, L., Fridley, B.L., FKBP51 affects cancer cell response to chemotherapy by negatively regulating akt (2009) Cancer Cell, 16, pp. 259-266
• Ni, L., Yang, C.S., Gioeli, D., FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells (2010) Mol Cell Biol, 30, pp. 1243-1253
• Romano, S., D'Angelillo, A., Pacelli, R., Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells (2010) Cell Death Differ, 17, pp. 145-157
• Mukaide, H., Adachi, Y., Taketani, S., FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma (2008) Cancer Invest, 26, pp. 385-390
• Callebaut, I., Renoir, J.M., Lebeau, M.C., An immunophilin that binds M(r) 90,000 heat shock protein: Main structural features of a mammalian p59 protein (1992) Proc Natl Acad Sci USA, 89, pp. 6270-6274
• Wu, B., Li, P., Liu, Y., 3D structure of human FK506-binding protein 52: Implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex (2004) Proc Natl Acad Sci USA, 101, pp. 8348-8353
• Pirkl, F., Buchner, J., Functional analysis of the Hsp90-associated human peptidyl prolyl cis/trans isomerases FKBP51, FKBP52 and Cyp40 (2001) J Mol Biol, 308, pp. 795-806
• Sinars, C.R., Cheung-Flynn, J., Rimerman, R.A., Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes (2003) Proc Natl Acad Sci USA, 100, pp. 868-873
• Riggs, D.L., Cox, M.B., Tardif, H.L., Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling (2007) Mol Cell Biol, 27, pp. 8658-8669
• Ward, B.K., Mark, P.J., Ingram, D.M., Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer (1999) Breast Cancer Res Treat, 58, pp. 267-280
• Shipp, C., Watson, K., Jones, G.L., Associations of HSP90 client proteins in human breast cancer (2011) Anticancer Res, 31, pp. 2095-2101
• Chen, H., Yong, W., Hinds, T.D., Jr., Fkbp52 regulates androgen receptor transactivation activity and male urethra morphogenesis (2010) J Biol Chem, 285, pp. 27776-27784
• Yang, Z., Wolf, I.M., Chen, H., FK506-binding protein 52 is essential to uterine reproductive physiology controlled by the progesterone receptor a isoform (2006) Mol Endocrinol, 20, pp. 2682-2694
• Tranguch, S., Cheung-Flynn, J., Daikoku, T., Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation (2005) Proc Natl Acad Sci USA, 102, pp. 14326-14331
• Cheung-Flynn, J., Prapapanich, V., Cox, M.B., Physiological role for the cochaperone FKBP52 in androgen receptor signaling (2005) Mol Endocrinol, 19, pp. 1654-1666
• Estebanez-Perpina, E., Arnold, L.A., Nguyen, P., A surface on the androgen receptor that allosterically regulates coactivator binding (2007) Proc Natl Acad Sci USA, 104, pp. 16074-16079
• Grosdidier, S., Fernandez-Recio, J., Protein-protein docking and hot-spot prediction for drug discovery (2012) Curr Pharm des, 18, pp. 4607-4618
• Grosdidier, S., Carbo, L.R., Buzon, V., Allosteric conversation in the androgen receptor ligand-binding domain surfaces (2012) Mol Endocrinol, 26, pp. 1078-1090
• De Leon, J.T., Iwai, A., Feau, C., Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells (2011) Proc Natl Acad Sci USA, 108, pp. 11878-11883
• Ott, M., Litzenburger, U.M., Rauschenbach, K.J., Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway (2015) Glia, 63, pp. 78-90
• Opitz, C.A., Litzenburger, U.M., Sahm, F., An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor (2011) Nature, 478, pp. 197-203
• Pilotte, L., Larrieu, P., Stroobant, V., Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase (2012) Proc Natl Acad Sci USA, 109, pp. 2497-2502
• Hoffmann, A., Natoli, G., Ghosh, G., Transcriptional regulation via the NF-kappaB signaling module (2006) Oncogene, 25, pp. 6706-6716
• Gilmore, T.D., The rel/NF-kappaB signal transduction pathway: Introduction (1999) Oncogene, 18, pp. 6842-6844
• Fan, Y., Gupta, N., Gelinas, C., (2006) Molecular Basis of Oncogenesis by NF-kB: From A Bird's Eye View to Relevant Role in Cancer, Ed, , Georgetown, Texas, USA: Landes Bioscience
• Erlejman, A.G., De Leo, S.A., Mazaira, G.I., NF-kappaB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: A ROLE for PEPTIDYL-PROLYL ISOMERASE ACTIVITY (2014) J Biol Chem, 289, pp. 26263-26276
• Hinz, M., Broemer, M., Arslan, S.C., Signal responsiveness of IkappaB kinases is determined by Cdc37-assisted transient interaction with Hsp90 (2007) J Biol Chem, 282, pp. 32311-32319
• Galigniana, M.D., Radanyi, C., Renoir, J.M., Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus (2001) J Biol Chem, 276, pp. 14884-14889
• Mikenberg, I., Widera, D., Kaus, A., Transcription factor NF-kappaB is transported to the nucleus via cytoplasmic dynein/dynactin motor complex in hippocampal neurons (2007) PLoS One, 2, p. e589
• Mackenzie, G.G., Keen, C.L., Oteiza, P.I., Microtubules are required for NF-kappaB nuclear translocation in neuroblastoma IMR-32 cells: Modulation by zinc (2006) J Neurochem, 99, pp. 402-415
• Riggs, D.L., Cox, M.B., Cheung-Flynn, J., Functional specificity of co-chaperone interactions with Hsp90 client proteins (2004) Crit Rev Biochem Mol Biol, 39, pp. 279-295
• Scheinman, R.I., Gualberto, A., Jewell, C.M., Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors (1995) Mol Cell Biol, 15, pp. 943-953
• Guo, G., Wang, T., Gao, Q., Expression of ErbB2 enhances radiation-induced NF-kappaB activation (2004) Oncogene, 23, pp. 535-545. , etal
• Cao, N., Li, S., Wang, Z., NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance (2009) Radiat Res, 171, pp. 9-21
• Shirane, M., Nakayama, K.I., Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis (2003) Nat Cell Biol, 5, pp. 28-37
• Choi, B.H., Yoon, H.S., FKBP38-Bcl-2 interaction: A novel link to chemoresistance (2011) Curr Opin Pharmacol, 11, pp. 354-359
• Kang, C.B., Feng, L., Chia, J., Molecular characterization of FK-506 binding protein 38 and its potential regulatory role on the anti-apoptotic protein Bcl-2 (2005) Biochem Biophys Res Commun, 337, pp. 30-38
• Bai, X., Ma, D., Liu, A., Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38 (2007) Science, 318, pp. 977-980
• Azmi, A.S., Wang, Z., Philip, P.A., Emerging Bcl-2 inhibitors for the treatment of cancer (2011) Expert Opin Emerg Drugs, 16, pp. 59-70
• Blaskovich, M.A., Yendluri, V., Lawrence, H.R., Lysophosphatidic acid acyltransferase beta regulates mTOR signaling (2013) PLoS One, 8, p. e78632
• Choi, M.S., Min, S.H., Jung, H., The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability (2011) Biochem Biophys Res Commun, 406, pp. 305-309
• Nakagawa, T., Shirane, M., Iemura, S., Anchoring of the 26S proteasome to the organellar membrane by FKBP38 (2007) Genes Cells, 12, pp. 709-719
• Choi, B.H., Feng, L., Yoon, H.S., FKBP38 protects Bcl-2 from caspase-dependent degradation (2010) J Biol Chem, 285, pp. 9770-9779
• Sagawa, Y., Fujitoh, A., Nishi, H., Establishment of three cisplatin-resistant endometrial cancer cell lines using two methods of cisplatin exposure (2011) Tumour Biol, 32, pp. 399-408
• Tabuchi, Y., Matsuoka, J., Gunduz, M., Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer (2009) Int J Oncol, 34, pp. 313-319
• Hadjidaniel, M.D., Reynolds, C.P., Antagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteins (2010) Mol Cancer Ther, 9, pp. 3164-3174
• Robson, T., Price, M.E., Moore, M.L., Increased repair and cell survival in cells treated with DIR1 antisense oligonucleotides: Implications for induced radioresistance (2000) Int J Radiat Biol, 76, pp. 617-623
• Jascur, T., Brickner, H., Salles-Passador, I., Regulation of p21(WAF1/CIP1) stability by WISp39, a Hsp90 binding TPR protein (2005) Mol Cell, 17, pp. 237-249
• Bublik, D.R., Scolz, M., Triolo, G., Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment (2010) J Biol Chem, 285, pp. 5274-5281
• Sunnotel, O., Hiripi, L., Lagan, K., Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: A case-control study (2010) Reprod Biol Endocrinol, 8, p. 22
• McKeen, H.D., Byrne, C., Jithesh, P.V., FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy (2010) Cancer Res, 70, pp. 1090-1100
• Abukhdeir, A.M., Vitolo, M.I., Argani, P., Tamoxifen-stimulated growth of breast cancer due to p21 loss (2008) Proc Natl Acad Sci USA, 105, pp. 288-293
• Valentine, A., O'Rourke, M., Yakkundi, A., FKBPL and peptide derivatives: Novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism (2011) Clin Cancer Res, 17, pp. 1044-1056
• Li, Y.Y., Liu, L.Q., Yang, J., [effect of WISp39 on proliferation, cell cycle and apoptosis of U937 cells] (2007) Zhongguo Shi Yan Xue Ye Xue Za Zhi, 15, pp. 733-737
• Erlejman, A.G., Lagadari, M., Galigniana, M.D., Hsp90-binding immunophilins as a potential new platform for drug treatment (2013) Future Med Chem, 5, pp. 591-607
• Liu, F., Wang, Y.Q., Meng, L., FK506-binding protein 12 ligands: A patent review (2013) Expert Opin Ther Pat, 23, pp. 1435-1449
• Ashida, T., Kikuchi, T., Estimation of relative binding free energy based on a free energy variational principle for the FKBP-ligand system (2013) J Comput Aided Mol des, 27, pp. 479-490
• Wang, Y., Kirschner, A., Fabian, A.K., Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control (2013) J Med Chem, 56, pp. 3922-3935
• Galat, A., Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands (2013) Cell Mol Life Sci, 70, pp. 3243-3275
• Schmidt, M.V., Paez-Pereda, M., Holsboer, F., The prospect of FKBP51 as a drug target (2012) ChemMedChem, 7, pp. 1351-1359
• Gaali, S., Kirschner, A., Cuboni, S., Selective inhibitors of the FK506-binding protein 51 by induced fit (2015) Nat Chem Biol, 11, pp. 33-37
• Bouwmeester, T., Bauch, A., Ruffner, H., A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway (2004) Nat Cell Biol, 6, pp. 97-105
• Giordano, A., Avellino, R., Ferraro, P., Rapamycin antagonizes NF-kappaB nuclear translocation activated by TNF-alpha in primary vascular smooth muscle cells and enhances apoptosis (2006) Am J Physiol Heart Circ Physiol, 290, pp. H2459-H2465
• Edlich, F., Weiwad, M., Wildemann, D., The specific FKBP38 inhibitor N-(N',N'-dimethylcarboxamidomethyl)cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia (2006) J Biol Chem, 281, pp. 14961-14970
• Robson, T., James, I.F., The therapeutic and diagnostic potential of FKBPL; A novel anticancer protein (2012) Drug Discov Today, 17, pp. 544-548
• Immecke, S.N., Baal, N., Wilhelm, J., The cyclophilin-binding agent sanglifehrin a is a dendritic cell chemokine and migration inhibitor (2011) PLoS One, 6, p. e18406
• Armand, P., Gannamaneni, S., Kim, H.T., Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning (2008) J Clin Oncol, 26, pp. 5767-5774
• Pulsipher, M.A., Langholz, B., Wall, D.A., The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: A phase 3 children's oncology group/pediatric blood and marrow transplant consortium trial (2014) Blood, 123, pp. 2017-2025
• Lupski, J.R., De Oca-Luna, R.M., Slaugenhaupt, S., DNA duplication associated with Charcot-Marie-tooth disease type 1A (1991) Cell, 66, pp. 219-232
• Wang, T., Li, B.Y., Danielson, P.D., The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type i receptors (1996) Cell, 86, pp. 435-444
• Cameron, A.M., Steiner, J.P., Roskams, A.J., Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux (1995) Cell, 83, pp. 463-472
• Jayaraman, T., Brillantes, A.M., Timerman, A.P., FK506 binding protein associated with the calcium release channel (ryanodine receptor) (1992) J Biol Chem, 267, pp. 9474-9477
• Gallo, L.I., Ghini, A.A., Piwien Pilipuk, G., Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity (2007) Biochemistry, 46, pp. 14044-14057
• Cox, M.B., Smith, D.F., (2006) Functions of the Hsp90-Bindign FKBP Immunophilins, , Eurekah.com, Blatch G.L. ed. The Networking of Chaperones by Cochaperones:, Landes Bioscience, Austin, Texas, USA
• Erlejman, A.G., Lagadari, M., Harris, D.C., Molecular chaperone activity and biological regulatory actions of the TPR-domain immunophilins FKBP51 and FKBP52 (2014) Curr Protein Pept Sci, 15, pp. 205-215
• Quintá, H.R., Maschi, D., Gomez-Sanchez, C., Piwien-Pilipuk, G., Galigniana, M.D., Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth (2010) J Neurochem, 115, pp. 716-734
• Sivils, J.C., Storer, C.L., Galigniana, M.D., Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52) (2011) Curr Opin Pharmacol, 11, pp. 314-319
• Sanokawa-Akakura, R., Dai, H., Akakura, S., A novel role for the immunophilin FKBP52 in copper transport (2004) J Biol Chem, 279, pp. 27845-27848
• Presman, D.M., Alvarez, L.D., Levi, V., Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids (2010) PLoS One, 5, p. e13279

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------